{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:46:23Z","timestamp":1785818783274,"version":"3.56.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The comorbidity burden of type 2 diabetes mellitus complicated with coronary heart disease is steadily increasing. However, there is a lack of systematic mapping of the research landscape, knowledge foundation, and emerging frontiers in this field.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search of the Web of Science Core Collection, PubMed, and Scopus was conducted for literature published from April 2016 to April 2026.\u00a0A series of tools, such as Origin Pro 2025, SCImago Graphica 1.0.55, VOSviewer 1.6.20, Bibliometrix R 4.6.0, and SciExplorer, were used to analyze annual trends, countries\/regions, institutions, authors, journals, highly cited references, keyword co-occurrence, and thematic evolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 8,390 publications were included, with annual output showing sustained growth. The United States and China emerged as the dominant contributors, and the United States displayed markedly higher international collaboration rates and greater citation impact per article. Institutions such as Harvard University and the University of Toronto anchored the core collaborative network.\n                      <jats:italic>Cardiovascular Diabetology<\/jats:italic>\n                      was identified as the most prolific journal. Highly cited documents predominantly comprised clinical guidelines and comprehensive reviews. Polygenic risk scores, machine learning applications, and the cardiovascular advantages of novel glucose-lowering agents are current research hotspots. Multi-omics investigations and integrated cardiometabolic multimorbidity management are gaining recognition as promising frontier directions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The past decade has witnessed a surge of research progress and innovation in this field. Capitalizing on the clinical translation of metabolomics, artificial intelligence-assisted decision-making, and integrated multimorbidity management represents a feasible pathway toward breakthrough research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1900634","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:27:28Z","timestamp":1785817648000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global research trends and hotspots evolution in type 2 diabetes mellitus complicated with coronary heart disease: a bibliometric analysis from 2016 to 2026"],"prefix":"10.3389","volume":"17","author":[{"given":"Chunying","family":"He","sequence":"first","affiliation":[{"name":"Institute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"NMPA Key Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"NMPA Key Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Digestive Diseases, Xiamen Traditional Chinese Medicine Hospital","place":["Xiamen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhan","sequence":"additional","affiliation":[{"name":"Department of Neurology, China Academy of Chinese Medical Sciences Xiyuan Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiYi","family":"Cao","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"NMPA Key Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology of Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology, China Academy of Chinese Medical Sciences","place":["Beijing, China"]},{"name":"NMPA Key Laboratory for Clinical Research and Evaluation of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Cardiology","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 esc guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the easd","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-025-02401-w","article-title":"Diabetes and its complications: molecular mechanisms, prevention and treatment","volume":"11","author":"Zhao","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001040","article-title":"Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: a scientific statement from the american heart association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, cardiovascular disease and the microcirculation","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet (London England)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.02.046","article-title":"Guidelines for cardiovascular risk reduction in patients with type 2 diabetes: jacc guideline comparison","volume":"79","author":"Kelsey","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.037492","article-title":"Optimal definition and risk stratification in prediabetes with stable coronary heart disease: a prospective cohort study","volume":"14","author":"Song","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-018-0080-2","article-title":"Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs","volume":"16","author":"Patti","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2024.12.030","article-title":"Anticoagulation and antiplatelet therapy for atrial fibrillation and stable coronary disease: meta-analysis of randomized trials","volume":"85","author":"Rashedi","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059595","article-title":"GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes","volume":"146","author":"Marx","year":"2022","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae047","article-title":"SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits","volume":"120","author":"Preda","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S2213-8587(25)00166-4","article-title":"Incretins and the cardiovascular system: bridging digestion with metabolism","volume":"13","author":"Avogaro","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2025.1029","article-title":"Oxidized lipoproteins as independent predictors of major adverse cardiovascular events in type 2 diabetes mellitus with coronary heart disease: a multicenter prospective cohort study","author":"Gu","year":"2026","journal-title":"Diabetes Metab J"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2026.1803996","article-title":"Interpretable machine learning of non-traditional lipid indices for diagnostic classification of chd in patients with comorbid masld and t2dm: a multicenter study","volume":"13","author":"Lv","year":"2026","journal-title":"Front Nutr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-022-24010-8","article-title":"Contributions toward sustainable development: a bibliometric analysis of sustainability reporting research","volume":"30","author":"Effah","year":"2023","journal-title":"Environ Sci pollut Res Int"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwad196","article-title":"Progression from different blood glucose states to cardiovascular diseases: a prospective study based on multi-state model","volume":"30","author":"Chen","year":"2023","journal-title":"Eur J Prev Cardiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.annepidem.2024.09.002","article-title":"Gestational diabetes mellitus, body mass index, and cardiometabolic multimorbidity: a prospective cohort study","volume":"99","author":"Zhang","year":"2024","journal-title":"Ann Epidemiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111982","article-title":"Physical activity guidelines for adults with type 2 diabetes: systematic review","volume":"220","author":"Tonga","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108365","article-title":"Identifying the quantity and assessing the quality of clinical practice guidelines for the treatment and management of type 2 diabetes: a systematic review","volume":"168","author":"Ng","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B21","doi-asserted-by":"publisher","first-page":"107726","DOI":"10.1016\/j.diabres.2019.05.005","article-title":"Series: implications of the recent cvots in type 2 diabetes: impact on guidelines: the endocrinologist point of view","volume":"159","author":"Scheen","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2019-0318","article-title":"Management of type 2 diabetes: now and the future","volume":"19","author":"Edeghere","year":"2019","journal-title":"Clin Med (London England)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","article-title":"Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from uk biobank","volume":"24","author":"Tian","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010119","article-title":"Potential workload in applying clinical practice guidelines for patients with chronic conditions and multimorbidity: a systematic analysis","volume":"6","author":"Buffel du Vaure","year":"2016","journal-title":"BMJ Open"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2015.97","article-title":"Exploring health system responsiveness in ambulatory care and disease management and its relation to other dimensions of health system performance (rac) - study design and methodology","volume":"4","author":"R\u00f6ttger","year":"2015","journal-title":"Int J Health Policy Manag"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-9-280","article-title":"Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in disease management program versus those in routine care: lutz registry","volume":"9","author":"Bestehorn","year":"2009","journal-title":"BMC Public Health"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e318273119b","article-title":"Patient complexity and risk factor control among multimorbid patients with type 2 diabetes: results from the r2d2c2 study","volume":"51","author":"Malik","year":"2013","journal-title":"Med Care"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00110","article-title":"Multi-omics analysis reveals micrornas associated with cardiometabolic traits","volume":"11","author":"Mens","year":"2020","journal-title":"Front Genet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.315898","article-title":"Metabolomics and proteomics in type 2 diabetes","volume":"126","author":"Chen","year":"2020","journal-title":"Circ Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12933-025-02718-4","article-title":"Integrative metabolomics and genomics reveal molecular signatures for type 2 diabetes and its cardiovascular complications","volume":"24","author":"Cheng","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v16.i7.106218","article-title":"Illuminating diabetes via multi-omics: unraveling disease mechanisms and advancing personalized therapy","volume":"16","author":"Song","year":"2025","journal-title":"World J Diabetes"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.125.005451","article-title":"Multiomics for risk stratification in atherosclerotic cardiovascular disease","volume":"19","author":"Nordestgaard","year":"2026","journal-title":"Circ Genomic Precis Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41591-022-01686-6","article-title":"Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease","volume":"28","author":"Talmor-Barkan","year":"2022","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1531525","article-title":"Coronary heart disease and type 2 diabetes metabolomic signatures in the middle east","volume":"16","author":"Elshrif","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042418-010924","article-title":"Omics and cardiometabolic disease risk prediction","volume":"71","author":"Tahir","year":"2020","journal-title":"Annu Rev Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S329787","article-title":"Pharmacogenomics and personalized medicine in type 2 diabetes mellitus: potential implications for clinical practice","volume":"14","author":"Venkatachalapathy","year":"2021","journal-title":"Pharmacogenomics Pers Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05844-9","article-title":"An atlas of genetic scores to predict multi-omic traits","volume":"616","author":"Xu","year":"2023","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-023-06027-x","article-title":"Multi-omic prediction of incident type 2 diabetes","volume":"67","author":"Carrasco-Zanini","year":"2024","journal-title":"Diabetologia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1236-x","article-title":"Longitudinal multi-omics of host-microbe dynamics in prediabetes","volume":"569","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27010136","article-title":"Integrative multi-omics and machine learning reveal shared biomarkers in type 2 diabetes and atherosclerosis","volume":"27","author":"Wu","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2542384","article-title":"Multi-omics integration reveals functional signatures of gut microbiome in atherosclerosis","volume":"17","author":"Shi","year":"2025","journal-title":"Gut Microbes"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14010072","article-title":"Oxidative stress and cardiovascular complications in type 2 diabetes: from pathophysiology to lifestyle modifications","volume":"14","author":"Caturano","year":"2025","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12933-025-03068-x","article-title":"Insulin resistance and coronary microvascular dysfunction: a complex interplay","volume":"25","author":"Magistri","year":"2026","journal-title":"Cardiovasc Diabetol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104548","article-title":"Molecular mechanisms of type 2 diabetes-related heart disease and therapeutic insights","volume":"26","author":"Giraldo-Gonzalez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2026.104270","article-title":"An integrative analysis of elementomics and oxidation-reduction potentials identifies redox-related metals associated with coronary artery disease and post-pci outcomes in type 2 diabetic patients","volume":"95","author":"Fang","year":"2026","journal-title":"Redox Biol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01857","article-title":"Therapeutic options targeting oxidative stress, mitochondrial dysfunction and inflammation to hinder the progression of vascular complications of diabetes","volume":"9","author":"Teodoro","year":"2019","journal-title":"Front Physiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14050572","article-title":"The dark triad of particulate matter, oxidative stress and coronary artery disease: what about the antioxidant therapeutic potential","volume":"14","author":"Grifoni","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti","year":"2022","journal-title":"Free Radical Biol Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030950","article-title":"Mechanistic insight into oxidative stress-triggered signaling pathways and type 2 diabetes","volume":"27","author":"Singh","year":"2022","journal-title":"Molecules (Basel Switzerland)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2023.0524","article-title":"Oxidative stress, endothelial dysfunction, and N-acetylcysteine in type 2 diabetes mellitus","volume":"40","author":"Li","year":"2024","journal-title":"Antioxid Redox Signal"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2025.13145","article-title":"Mitochondrial dysfunction, reactive oxygen species, and diabetes mellitus - a triangular relationship: a review","volume":"26","author":"Manojlovic","year":"2025","journal-title":"Biomolecules Biomedicine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2024.0706","article-title":"Endothelial reactive oxygen species: key players in cardiovascular health and disease","volume":"42","author":"Craige","year":"2025","journal-title":"Antioxid Redox Signal"},{"key":"B53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12933-020-00998-6","article-title":"Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus","volume":"19","author":"Wang","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1268308","article-title":"Hexokinase-linked glycolytic overload and unscheduled glycolysis in hyperglycemia-induced pathogenesis of insulin resistance, beta-cell glucotoxicity, and diabetic vascular complications","volume":"14","author":"Rabbani","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.freeradbiomed.2024.01.015","article-title":"Cardiovascular benefits of SGLT2 inhibitors and GLP-1 receptor agonists through effects on mitochondrial function and oxidative stress","volume":"213","author":"Luna-Marco","year":"2024","journal-title":"Free Radical Biol Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146777","article-title":"Molecular insights into the potential cardiometabolic effects of GLP-1 receptor analogs and DPP-4 inhibitors","volume":"26","author":"Kr\u00f3l","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12081643","article-title":"Multi-omics approach reveals prebiotic and potential antioxidant effects of essential oils from the Mediterranean diet on cardiometabolic disorder using humanized gnotobiotic mice","volume":"12","author":"S\u00e1nchez-Quintero","year":"2023","journal-title":"Antioxidants (Basel Switzerland)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-025-01144-7","article-title":"Single cell and spatial transcriptomic profiling of the type 2 diabetic coronary microcirculation and myocardium","volume":"120","author":"McCallinhart","year":"2025","journal-title":"Basic Res Cardiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1900634\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:27:29Z","timestamp":1785817649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1900634\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":58,"alternative-id":["10.3389\/fendo.2026.1900634"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1900634","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"article-number":"1900634"}}